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p53 Deficiency Rescues the Adverse Effects
of Telomere Loss and Cooperates with Telomere
Dysfunction to Accelerate Carcinogenesis
Most somatic human tissues and primary cells pos-
sess low or undetectable telomerase activity, and telo-
meres shorten with each cell division in vivo and in vitro.
In human cells, a critical telomere length is eventually
reached that induces cellular senescence, thus limiting
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limit (Hayflick and Moorhead, 1961). The telomere signal44 Binney Street
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the RB and p53 pathways, since cell division beyond2 Department of Medicine and Genetics
the Hayflick limit can occur after antisense neutralization3 Department of Dermatology
(Hara et al., 1991) or viral oncoprotein inactivation of RBHarvard Medical School
and p53 (Shay et al., 1991). Ectopically expressed hTERTBoston, Massachusetts 02115
maintains telomere length and allows unlimited growth4 Quest Diagnostics Inc.
(Bodnar et al., 1998; Counter et al., 1998; Vaziri andAnatomical Pathology
Benchimol, 1998). Thus, telomere shortening in the ab-Teterboro, New Jersey 07608
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entry into senescence, although immortalization of someJohns Hopkins University School of Medicine
epithelial cells requires not only TERT expression butBaltimore, Maryland 21205
also compromise of the RB pathway (Kiyono et al., 1998).
In primary cells deficient for Rb and p53, continued
cellular growth beyond the Hayflick limit results in severeSummary
telomere shortening, marked genetic instability, and mas-
sive cell deathÐa period referred to as crisis (CounterMaintenance of telomere length and function is critical
et al., 1992). The prominent block to continued prolifera-for the efficient proliferation of eukaryotic cells. Here,
tion at crisis led to the suggestion that the cell deathwe examine the interactions between telomere dysfunc-
associated with telomere dysfunction and genetic in-tion and p53 in cells and organs of telomerase-defi-
stability represents a tumor suppression mechanism de-cient mice. Coincident with severe telomere shortening
signed to efficiently eliminate premalignant cells. Al-and associated genomic instability, p53 is activated,
though most cells transiting through crisis die, rareleading to growth arrest and/or apoptosis. Deletion of
survivor cells emerge that can now maintain telomerep53 significantly attenuated the adverse cellular and
length through either activation of telomerase or utiliza-organismal effects of telomere dysfunction, but only
tion of an alternative pathway thought to involve a re-during the earliest stages of genetic crisis. Corre-
combination-based mechanism (ALT). Such a mecha-spondingly, the loss of telomere function and p53 defi-
nism has been demonstrated in yeast (Lundblad andciency cooperated to initiate the transformation pro-
Blackburn, 1993; McEachern and Blackburn, 1996). Thecess. Together, these studies establish a key role for
notion that telomere function may indeed be requiredp53 in the cellular response to telomere dysfunction
for immortalization is supported by the frequent activa-in both normal and neoplastic cells, question the sig-
tion of telomerase or ALT in human cancers (Kim et al.,nificance of crisis as a tumor suppressor mechanism,
1994; Bryan et al., 1995).
and identify a biologically relevant stage of advanced
To explore the effect of telomere loss in vivo, telo-
crisis, termed genetic catastrophe.
merase-deficient mice were generated by deletion of
the mTR gene. Due to the very long telomeres of Mus
musculus, critical reduction in telomere length and chro-Introduction
mosomal instability is only seen following extensive pas-
sage of mTR2/2 cells (Niida et al., 1998), after successiveTelomeres are nucleoprotein structures that serve a crit-
generations of mTR2/2 mice (Blasco et al., 1997; Lee etical function in protecting the ends of linear chromo-
al., 1998), or in aged mTR2/2 organs with high prolifera-somes. Maintenance of telomere length and function re-
tive histories (Rudolph et al., 1999). Telomere shorteningquires telomerase, a specialized reverse transcriptase,
and genetic instability in late-generation mTR2/2 mice
as well as a complex of telomere-associated proteins
is associated with germ cell depletion in the testis, uter-
(van Steensel and de Lange, 1997; van Steensel et al.,
ine and intestinal villus atrophy, impaired mitogenic re-
1998). Telomerase is comprised of essential catalytic sponses of lymphocytes, diminished hematopoietic re-
(telomerase reverse transcriptase [TERT]) and RNA com- serve, and an ulcerative dermatitis. The mechanism
ponents (telomerase RNA [TR]) (reviewed in Greider, underlying organ compromise appears to be apoptosis
1998). The RNA subunit provides the template for telomere in most cell types but can involve proliferative defects
repeat synthesis (Greider and Blackburn, 1989; Yu et al., alone or in combination with apoptosis. The signals and
1990). pathways mediating these cellular responses associ-
ated with telomere dysfunction have yet to be defined
in mammalian cells. In yeast, deletion of critical genes6 To whom correspondence should be addressed (e-mail: ron_
required for telomere maintenance results in telomeredepinho@dfci.harvard.edu).
7These authors contributed equally to this work. shortening and progressive cell death. In addition, the
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RAD9-dependent DNA damage checkpoint is induced organ systems (Lee et al., 1998; Rudolph et al., 1999).
The hypocellularity, abnormal cytoarchitecture, and di-by a single broken chromosome end (Sandell and Zak-
minished proliferative potential of these organ systemsian, 1993). The RAD9 and MEC1 DNA damage response
and cell types are due to a combination of apoptosis andpathways in yeast are thought to be similar to the p53
growth arrest. We reasoned that shortened telomeres,checkpoint in mammalian cells.
exposed chromosomal termini, and/or chromosomal fu-Strikingly, as mTR2/2 mice advance with age and gen-
sion-bridge-breakage events might be recognized aseration, an increase in cancer incidence is observed
a DNA damage signal and thus activate p53 and itspresumably due to increased genetic instability caused
associated checkpoint functions.by telomere shortening, repeated chromosomal fusion-
To test this hypothesis, the levels and activity of p53bridge-breakage cycles, and chromosomal loss (Rudolph
were assessed in primary tissues and cells derived fromet al., 1999). These experimental data challenged the
late-generation mTR2/2 mice. Immunoprecipitation andsimplistic view that telomere dysfunction and genetic
Western blot analysis readily detected p53 in lysatesinstability associated with crisis act as a tumor suppres-
from G6 mTR2/2 testis, but not in lysates derived fromsor. Indeed, the impact of telomere dysfunction on im-
age-matched mTR1/1 testis or from G6 mTR2/2 p532/2mortalization and tumorigenesis is complex. In cancer-
littermate controls (Figure 1A). This induction of p53prone mice rendered doubly null for the INK4a tumor
coincides with the dramatic increase in apoptosis (assuppressor and mTR, shortened telomeres markedly
assessed by TUNEL) and decreased cellularity in the G6reduced both cancer incidence and transformation by
mTR2/2 testis (Lee et al., 1998). Since the role of p53 incellular oncogenes (Greenberg et al., 1999 [this issue
DNA damage pathways has been extensively investi-of Cell]). In contrast, SV40 large T antigen efficiently
gated in mouse embryo fibroblasts (MEFs) (Harvey ettransformed cells from late-generation mTR2/2 mice de-
al., 1993; Lowe et al., 1993; Deng et al., 1995; Kamijo etspite evidence for telomere dysfunction (Blasco et al.,
al., 1997), we assayed p53 protein levels and activity in1997; Greenberg et al., 1999). The inactivation of Rb
early-passage MEFs. MEFs from mTR1/1 mice and fromand/or p53 may account for the efficient transformation
late-generation mTR2/2 mice exhibited marked differ-of cells with significant telomere loss by SV40 large
ences in the proportion of cells expressing p53 as deter-T antigen. These results indicate that the oncogenic
mined by immunohistochemistry. Whereas only 21% ofpotential of a would-be cancer cell bearing short telo-
the mTR1/1 MEFs at passage 6 stained positive for p53,meres may depend upon its genetic profile.
more than 80% of MEFs derived from G4 and G6 exhib-The contrasting effect of telomere loss on cellular
ited strong immunoreactivity to p53 (Figure 1B, comparetransformation phenotypes in cells that have intact or
[a] with [b] and [c]).inactivated DNA damage pathways suggested that the
Activation of p53 involves protein stabilization andp53 pathway may alter the cellular response to telomere
posttranslational modifications (Prives, 1998). Theseloss in both normal and neoplastic cells. p53 is a tumor
modifications allow p53 to activate specific target genes.suppressor that serves to protect the cell from a variety
One of these targets is the CDK inhibitor p21CIP1/WAF1,of genotoxic and environmental stresses, including DNA
which can induce a G1 or G2 cell cycle block. Endoge-damage, hypoxia, nucleotide depletion, and inappropri-
nous p21CIP1/WAF1 levels were increased 3- to 4-fold inate growth signals from activated oncogenes. Induction
late-generation G6 mTR2/2 p531/1 MEFs compared toof double strand breaks in DNA by ionizing radiation or
early-generation G2 mTR2/2 p531/1 MEFs (Figure 1C).genotoxic chemotherapy leads to the rapid stabilization
Because G2 mTR2/2 and G6 mTR2/2 MEFs both lackof p53 through phosphorylation of its N terminus (Shieh
telomerase activity, we conclude that telomere shorten-et al., 1997; Siliciano et al., 1997). This stabilization re-
ing or associated chromosome fusions and breakagesults in either cell cycle arrest via transcriptional induc-
rather than telomerase deficiency per se signals to p53tion of the p21CIP1/WAF1 CDK inhibitor or apoptosis (re-
and accounts for p21CIP1/WAF1 induction. As anticipated,viewed in Levine, 1997). In senescent human and mouse
p21CIP1/WAF1 was not detected in G6 mTR2/2 p532/2 cells,cells, p53 and p21CIP1/WAF1 are coordinately activated,
indicating that p21CIP1/WAF1 induction in mTR2/2 cells issuggesting that there may be overlapping pathways that
largely p53 dependent. To further assess p53 activation,
signal senescence and DNA damage. Here, we exam-
MEF cultures were transfected with pG13CAT, a CAT
ined the functional interactions between telomere dys-
reporter plasmid containing a multimerized p53-binding
function and p53 in cells and organs of late-generation site and a minimal TATA box element (Kern et al., 1992).
mTR2/2 mice. We found that p53 mediates the adverse After normalization for transfection efficiency, CAT ac-
effects of critically shortened telomeres. Furthermore, tivity was increased approximately 2-fold in G6 mTR2/2
loss of telomere function and p53 deficiency can coop- MEFs compared to mTR1/1 p531/1 controls at identical
erate to enhance transformation. Our findings under- passage number (Figure 1D). This activity was strictly
score the importance of p53 in a pathway that responds dependent upon p53, since p532/2 and G6 mTR2/2
to telomere dysfunction and suggest new roles for crisis p532/2 MEF cultures showed only background levels of
in cellular transformation. CAT activity. Together, these data indicate that critical
telomere shortening and the associated chromosomal
Results instability correlate with an increase in the level and the
activation of the p53 protein.
Critical Telomere Shortening Stabilizes
and Activates the p53 Protein Effect of p53 Deficiency on mTR Null
Loss of telomere function in late-generation (G4 onward) Phenotype In Vivo
mTR2/2 mice has been shown to adversely affect the To determine the effect of p53 loss on mTR phenotypes
in vivo, we generated mice doubly null for mTR and p53.morphology and physiology of diverse cell types and
p53 Mediates the Adverse Effects of Telomere Loss
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Figure 1. Stabilization and Activation of p53
Protein in Late-Generation mTR-Deficient
Testis and MEFs
(A) IP-Western blot assay of testis extract. IP
and IB Ab: a-p53. Asterisk indicates location
of the p53 band.
(B) a-p53 immunoperoxidase staining of pas-
sage 6 MEFs. Increased p53 protein levels
as evidenced by an increasing percentage of
nuclei exhibiting a-p53 immunoreactivity: (a)
mTR1/1 MEF, 21% positive; (b) G4 mTR2/2
MEF, 82% positive; (c) G6 mTR2/2 MEF, 88%
positive; (d) negative control, G6 mTR2/2 MEF,
with no primary antibody. Note the marked
senescent morphology of G6 mTR2/2 MEFs.
(C) Western blot analysis of early-passage
MEF lysates for p21CIP1/WAF1 protein. (Top)
a-p21CIP1/WAF1 antibody. (Bottom) a-tubulin an-
tibody as loading control.
(D) p53-dependent CAT reporter assays doc-
umenting activation of p53 protein in G6
mTR2/2 MEFs. CAT activities are normalized
for transfection efficiency.
(E) p53 genotype distribution of live mice born
in successive generations of mTR2/2 p531/2
intercrosses expressed as a percentage of all
mice within a generation (n 5 total number).
Note increasing percentage of p532/2 mice
in G7 and G8.
Successive generational intercrosses were carried out of late-generation mTR2/2 embryos experience delayed
neural tube closure resulting in diminished litter sizesto produce cohorts with progressively shorter telomeres
as described previously (Lee et al., 1998; Rudolph et al., with advancing mTR2/2 generations (Herrera et al.,
1999). Moreover, p53 deficiency itself leads to exen-1999). For these matings, the p53 status was maintained
in the heterozygous state to avoid potential broad geno- cephaly in a proportion of females, which accounts for
underrepresentation of p532/2 females arising from het-mic effects arising from p53 deficiency. This mating
scheme also produced p531/1 and p532/2 littermate erozygous intercrosses (Sah et al., 1995). If p53 defi-
ciency does indeed attenuate the adverse effects ofcontrols for each mTR2/2 generation.
Telomere dysfunction results in a dramatic reduction short dysfunctional telomeres, then one might expect
to see an overrepresentation of p53 null pups. The geno-in reproductive competence in late-generation (G6)
mTR2/2 p531/1 mice (Lee et al., 1998). In the G6 mTR2/2 type distribution of all live mice generated through
mTR2/2 p531/2 intercrosses was determined at 10 daysp531/2 intercrosses, we observed an unusually high rate
of productive mating pairs (11 of 22 mating pairs) com- of age. p532/2 mice were underrepresented as a per-
centage of total mice in late-generation mTR2/2 back-pared to G6 mTR2/2 p531/1 matings (Lee et al., 1998),
although fertility was still reduced compared to wild- ground (19%, 15%, and 14% for G4, G5, and G6 respec-
tively) (Figure 1E). However, a relative increase in p532/2type controls (data not shown). Significantly, we also
observed productive matings arising from G7 mTR2/2 mice was evident in G7 and G8 mTR2/2 background
(24% and 38%, respectively). Since there is progressivep531/2 pairs (5 of 17 mating pairs) to yield G8 mTR2/2
offspring of all three p53 genotypes. Because p53 het- telomere shortening and telomere dysfunction in suc-
cessive generations, mice in G4±G6 were pooled anderozygous mice exhibit haploinsufficiency in a number
of assays (Gottlieb et al., 1997; Venkatachalam et al., compared to mice in G7±G8. Significantly, 15% of the
G4±G6 mTR2/2 mice (86 out of 565 mice) were p532/21998), we speculated that the increased fecundity of the
G6 and G7 mTR2/2 p531/2 mice could relate to increased compared to 26% of the G7±G8 mTR2/2 mice (24 of 91
mice) (p 5 0.015 by Fisher's two-sided t test) (Figure 1E).survival of germ cells in the p531/2 background.
Previous studies have shown that a small percentage These data indicate that as telomere function worsens in
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Figure 2. Telomere Dysfunction Induces Germ Cell Depletion by p53-Dependent and Independent Mechanisms
(A) Representative photo of isolated testes from age-matched males with indicated genotypes. Note capsule of mTR1/1 p532/2 testis was
ruptured accidentally.
(B) Photomicrographs of representative histological sections across seminiferous tubules of testes isolated from age-matched adult males.
(Left panel, top) mTR1/1 p531/1; (left panel, bottom) mTR1/1 p532/2; H&E, 103. Note p53 deficiency did not alter morphology of the seminiferous
tubules. (Middle panel, top) G6 mTR2/2 p531/1; (middle panel, bottom) G6 mTR2/2 p532/2; H&E, 103. Note the marked germ cell depletion
(manifested as vacuole-like empty space within seminiferous tubules) in G6 mTR2/2 p531/1 testis is completely reversed in G6 mTR2/2
p532/2 testis (compare top with bottom panel). (Right panel) same samples as middle panel; PAS, 403. PAS stain reveals that all stages of
spermatogenesis are present in the G6 mTR2/2 p532/2 testis. Again note marked germ cell depletion in G6 mTR2/2 p531/1 testis (compare
top with bottom of right panel).
(C) Photomicrographs of representative TUNEL assay for apoptosis in age-matched adult testis. Note dramatic increase in number of TUNEL-
positive nuclei in G6 mTR2/2 p531/1 testis, which is largely rescued by p53 deficiency in the G6 mTR2/2 p532/2 testis. Arrows, TUNEL-positive
nuclei.
(D) p53 deficiency does not rescue germ cell depletion in G8 mTR2/2 testis. G8 mTR2/2 p531/1, H&E, 103, top left; 403, top right. G8 mTR2/2
p532/2, H&E, 103, bottom left; 403, bottom right. Note extensive germ cell loss in both samples. The p53-independent germ cell elimination
in G8 mTR2/2 testis provides evidence for late crisis in vivo. Arrow shows single tubule with spermatogenesis. Asterisk indicates interstitial
hyperplasia.
G7 and G8, p531/1 and p531/2 mice are at a significant (1/1 or 1/2) or deficient (2/2) were examined on both
survival disadvantage compared to p532/2 mice. These macroscopic and microscopic levels. In mTR1/1 testis,
organismal findings prompted a more thorough assess- p53 status did not affect testicular volume or signifi-
ment of how loss of p53 impacts on organ systems cantly alter the cytoarchitecture of seminiferous tubules
adversely affected by telomere dysfunction. (Figures 2A and 2B). In mTR2/2 mice, a decrease in testis
size that correlated with germ cell depletion by histology
was first evident in G5 mTR2/2 animals and becameRole of p53 in Germ Cell Apoptosis
more prevalent in G6 mTR2/2 mice (Lee et al., 1998).in Late-Generation mTR2/2 Testis
Gross testis size was consistently rescued to near nor-Telomere loss in late-generation mTR2/2 testis culmi-
mal in G6 mTR2/2 p532/2 mice compared to G6 mTR2/2nates in sterility due to an apoptotic elimination of germ
p531/1 littermates (see Figure 2A for representative com-cells (Lee et al., 1998). To determine the impact of pro-
parison). Using a scoring system of normal, 11, 21, orgressive telomere dysfunction on testis cellularity and
31 to reflect progressive germ cell depletion and tubulararchitecture as well as to assess the in vivo relevance
atrophy, we examined in more detail the microscopicof p53 upregulation in this process, testis samples from
late-generation mTR2/2 mice that were p53 competent changes associated with telomere dysfunction in late-
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prior to FACS analysis. As shown in Figure 3A, DNATable 1. Degree of Germ Cell Depletion in Age-Matched mTR2/2
content analyses of G6 mTR2/2 p531/1 MEFs revealedTestes
a profile consistent with a biphasic block as evidenced
p531/1 or p531/2 p532/2
by marked accumulation of cells in G1 and G2/M phases.
G5 mTR2/2 Normal Normal Accordingly, BrdU incorporation assay showed that
Normal Normal 36% of the G6 mTR2/2 p531/1 cells were in G1 phase,
21 atrophy Normal 3% were in S phase, and 40% were in G2/M (Figure 3A,
G6 mTR2/2 Normal Normal top panel). In contrast, mTR1/1 p531/1 MEF cultures
11 atrophy Normal demonstrated 35% of cells in S phase and only 13% in
11 atrophy Normal G2/M. Consistent with the established role of p53 and
21 atrophy Normal
p21CIP1/WAF1 in mediating a biphasic arrest in response to21 atrophy 11 atrophy
DNA damage signals (Brugarolas et al., 1995; Deng et31 atrophy 21 atrophy
al., 1995; Bunz et al., 1998) loss of p53 abrogated thisNormal 21 atrophy
block. Modest attenuation of the cell cycle block wasG7 mTR2/2 31 atrophy 11 atrophy
evident in the G6 mTR2/2 p531/2 cultures, suggesting31 atrophy 11 atrophy
functional haploinsufficiency. However, loss of p53 does11 atrophy 21 atrophy
not appear to eliminate the cell cycle blocks completely,
G8 mTR2/2 3 1 atrophy 11 atrophy
since G6 mTR2/2 p532/2 MEFs still exhibited fewer cells3 1 atrophy 31 atrophy
in S phase (33% vs. 55%) and more cells in G2/M (14%
H&E sections of age-matched testis samples were examined and vs. 7%) than mTR1/1 p532/2 MEFs. Thus, both the apo-
scored as follows: Normal 5 normal testis histology; 11 atrophy 5
ptotic response and cell cycle arrest induced by telo-
,10% of the tubules exhibited atrophy; 21 atrophy 5 z50% of
mere dysfunction are mediated by p53.the tubules are abnormal; 31 atrophy 5 .90% to total germ cell
depletion.
Telomere Length and Cytogenetic Profile
in the Absence of p53
To rule out the possibility that p53 status influences
generation mTR2/2 mice (Table 1). Most of the G5±G7 telomere metabolism, flow FISH methodology was uti-
mTR2/2 p532/2 mice showed improved histology com- lized to determine relative telomere lengths in multiple
pared to their age-matched controls with competent independent MEF and thymocyte cultures. As shown in
p53 function. TUNEL assays demonstrated that the res- Figure 3B, all of the G6 mTR2/2 MEF cultures regardless
toration of germ cells in the G5±G7 mTR2/2 p532/2 testis of p53 status exhibited an equivalent and marked de-
is accompanied by a dramatic reduction of apoptosis cline in mean telomere signal relative to mTR1/1 MEFs
to levels observed in mTR1/1 testis (Figure 2C). These (75% reduction). Similar results were obtained for pri-
findings indicate that germ cell apoptosis coincident mary thymocytes, irrespective of p53 status (Figure 3C).
with telomere loss is mediated by p53. Telomere shortening in mTR2/2 mice results in loss of
As telomere function worsens in later generations of telomere function and chromosome end-to-end fusion
mTR deficiency, germ cell death by p53-independent (Blasco et al., 1997; Rudolph et al., 1999). Cells with
mechanisms becomes evident. Whereas all G5 mTR2/2 short telomeres and intact p53-mediated DNA damage
p532/2 testes exhibited normal histology, 3 of 7 G6 responses may be more efficiently ªculledº from the
mTR2/2 p532/2 samples still showed varying degrees of population (via apoptosis or arrest); therefore, p53 null
pathology (Table 1). Furthermore, p53-independent cell cells may accumulate more end-to-end fusions than
death becomes a more consistent feature in G7 and G8, their p531/1 counterparts. Indeed, analysis of meta-
since all of the five G7±G8 mTR2/2 p532/2 testis samples phase spreads derived from G6 mTR2/2 p531/1 MEFs
showed significant germ cell depletion microscopically showed a rate of 0.42 (SD 0.71) chromosomal fusions
(Figure 2D). Of note, the G8 mTR2/2 p532/2 mouse that per metaphase, a rate consistent with previous studies
exhibited a relatively normal histology (11 germ cell (Figure 3D) (Blasco et al., 1997; Greenberg et al., 1999;
depletion, Table 1) had significantly longer telomere Rudolph et al., 1999). By comparison, G6 mTR2/2 p532/2
length by flow FISH determination (data not shown) than MEFs exhibited 1.65 (SD 2.59) fusions per metaphase, a
the other G8 mTR2/2 p532/2 mouse. Therefore, cell death 3-fold increase (p 5 0.012). Together, these data indicate
in the context of extreme telomere dysfunction, genetic that p53 deficiency restores neither telomere length nor
instability, and p53 deficiency in G7 and G8 mTR2/2 function in the telomerase-deficient mouse. The rescue
mice may represent a more accurate model of the late of proliferation, cellularity, and cell death is therefore
stage of crisis experienced by human cells that bypass due to loss of p53 checkpoint functions. Continued pro-
liferation in the absence of the p53 checkpoint maysenescence (see Discussion).
lead to an increased loss of telomere sequences and
therefore account for the increased frequency of chro-
mosome fusions.p53-Dependent Biphasic Arrest in Late-Generation
mTR2/2 MEF Cultures
Activation of p53 and p21CIP1/WAF1 via classical DNA dam- Tumorigenic Initiation and Progression
age stimuli typically results in a block in cell cycle pro- in the Setting of Telomere Dysfunction
gression. To determine whether telomere loss induces and p53 Deficiency
such a block, subconfluent early-passage MEFs were The finding that p53 loss enables survival in the face of
telomere dysfunction raised the distinct possibility thattreated with BrdU and labeled with propidium iodide
Cell
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Figure 3. Cell Cycle Analysis, Cytogenetics, and Telomere Lengths in MEFs
(A) Induction of p53-dependent biphasic blocks in late-generation mTR2/2 MEFs. Representative cell cycle profile and BrdU incorporation of
early-passage (p4) MEFs. Note prominent G2 peaks in G6 mTR2/2 p531/1 and G6 mTR2/2 p531/2 cultures (representative of five independent
cultures examined). Insets: dot plot representations of BrdU incorporation of the corresponding MEF cultures. Red dots represent cells in G1
phase of the cell cycle, green dots represent cells in G2, and blue dots represent cells actively incorporating BrdU. Table: percentage of cells
in each phase of the cell cycle according to BrdU incorporation assays.
(B and C) Relative telomere lengths in early-passage G6 mTR2/2 MEF cultures (B) or primary thymocytes (C) derived from littermates. Note
that telomere lengths are reduced in G6 mTR2/2 cells and are not significantly affected by p53 deficiency. For mTR1/1 p531/1 MEFs, data are
pooled from two independent cultures. Telomere lengths are expressed as mean absolute flouresence units (AFU) minus mean background
autoflouresence. For thymocytes, n 5 3 mice. p values were calculated by one-tailed Student's t test.
(D) Cytogenetics in two independent MEF cultures was analyzed for both G6 mTR2/2 p531/1 and G6 mTR2/2 p532/2. Increased chromosomal
fusions (p 5 0.012) and aneuploidy are evident in MEFs from p532/2 littermates.
p53 Mediates the Adverse Effects of Telomere Loss
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Table 2. Myc/RAS Transformation Assays with or without Exogenous Telomerase Reconstitution
Avg. Foci Number per 10 cm Plate
MEF Culture Experiment Myc/RAS 1 mTR Myc/RAS 1 Vector Statistics
448.1 G6 mTR2/2 p532/2 1 18 33 p 5 0.013
2 20 58
3 47 45
4 21 55
5 62 97
448.3 G6 mTR2/2 p532/2 2 30 74 p 5 0.011
3 35 97
4 12 52
5 41 62
448.4 G6 mTR2/2 p532/2 2 36 47 p 5 0.015
3 20 45
4 36 47
5 42 94
448.8 G6 mTR2/2 p532/2 1 1 7 p 5 0.038
2 5 11
3 6 17
4 26 27
5 11 22
G5 mTR2/2 INK4a2/2 5 8 2 ND
Each experiment represents an independent precipitate. Averaged foci counts were obtained by counting two to six 10 cm transfected plates.
Foci number generated by Myc/RAS 1 mTR transfection was taken as 100% in each experiment, and foci count generated by Myc/RAS 1
vector transfection was calculated as percentage of the Myc/RAS 1 mTR transfection and plotted in Figure 4A. Statistical analyses were
performed using a one-tailed Student's t test.
ND, not determined.
loss of telomere function and the consequent genomic cell lines compared with only 19 of 32 (59%) vector foci
(Figure 4C, p value 5 0.018). Similar differences wereinstability could cooperate with p53 deficiency to initiate
the process of cellular transformation. To test this hy- observed in low-density seeding experiments (data not
shown). However, when these established cell lines werepothesis, we exploited the quantitative Myc/RAS coop-
eration assay (Land et al., 1983; Mukherjee et al., 1992). injected into SCID mice, mTR lines and vector lines
formed tumors with similar efficiency (Figure 4D). Fur-This assay allows for development of the malignant phe-
notype to be observed over time from focus formation thermore, the average weight of mTR tumors was not
significantly different from that of the vector tumors.to establishment of permanent cell lines to tumor forma-
tion in SCID mice. Cotransfections of Myc/RAS plus Taken together, the differences in the subcloning effi-
ciency of the mTR versus vector cells and their similarityeither an empty plasmid (ªvectorº) or a genomic frag-
ment encoding the mTR gene (ªmTRº) were performed in tumorigenic potential following prolonged passage
in culture argue that telomerase provides a significantin multiple independent experiments on several inde-
pendently-derived G6 mTR2/2 p532/2 MEF cultures, and advantage in steps following the initiation of cellular
transformation. However, once telomerase-deficient cellsthe rates of focus formation were determined (Table
2 and Figure 4A). Transfection of this mTR genomic have adapted to the existing telomere dysfunction, they
grow as efficiently as telomerase-expressing cells. Thefragment restored telomerase activity in mTR2/2 cells
(Figure 4B). In contrast to the findings that telomerase mechanisms by which tumorigenic potential is main-
tained in these late stages of tumorigenesis in the pres-reconstitution enhanced focus formation in G5 mTR2/2
INK4a2/2 MEFs (Greenberg et al., 1999), we demon- ence of telomere dysfunction remain to be determined.
strated that the addition of mTR consistently sup-
pressed the rate of Myc/RAS focus formation in G6 Discussion
mTR2/2 p532/2 MEFs (Table 2), while restoration of telo-
merase activity in mTR1/1 p532/2 MEFs had no signifi- As telomerase-deficient cells traverse replicative senes-
cence via loss of RB/p16INK4a and/or p53/p19ARF or over-cant effect (data not shown). These results indicate that
telomere dyfunction acts synergistically with p53 defi- expression of Myc, continued telomere attrition results
in the loss of chromosomal integrity with consequentciency to initiate malignant transformation, presumably
by enhancing genetic instability. genetic instability. The cellular response to this genomic
crisis is varied, complex, and poorly understood. RecentFocus formation represents an early step in transfor-
mation. To determine the effect of telomere dysfunction results have shown that removing the telomere-binding
protein TRF2 from telomeres will directly activate a p53-on subsequent steps, subcloning efficiency was deter-
mined. Despite a lower rate of focus formation, Myc/ dependent apoptosis pathway (Karleseder et al., 1999).
Whether loss of TRF2 binding, or short telomeres orRAS foci transfected with mTR exhibited a significant
enhancement in subcloning efficiencyÐ23 of 26 (89%) cycles of fusion-bridge-breakage formation mediate the
p53 induction described in this report remains to bemTR foci were successfully established as permanent
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Figure 4. Telomere Dysfunction Can Drive Tumorigenic Initiation but Not Progression
(A) Myc/RAS focus formation of four independent G6 mTR2/2 p532/2 MEF cultures. Histograms show relative transformed foci counts derived
from transfections that included an ªmTRº expression plasmid (red hatched bars) or empty ªvectorº control (stippled blue bars). Foci counts
in Myc1RAS1mTR cotransfection were taken as 100%, and data from five experiments (shown in Table 2) are pooled. For G5 mTR2/2 INK4a2/2
MEF, p10 culture was used in the same experiment as the G6 mTR2/2 p532/2 MEFs.
(B) Telomerase activity is reconstituted by expression of mTR in transformed clones and absent in vector clones. TRAP assay was performed
as described previously (Blasco et al., 1997) on extracts from two independent mTR or vector cotransfected Myc/RAS transformed clones.
HI, heat inactivation; IC, internal control.
(C) Subcloning efficiency of Myc/RAS transformed G6 mTR2/2 p532/2 MEFs was enhanced by mTR compared to vector.
(D) Tumorigenic potential of established subclones was determined by tumor growth in mice. Cells (2 3 106) from each of the 12 Myc1RAS1vec-
tor subclones and 13 Myc1RAS1mTR subclones were injected subcutaneously into SCID mice, and tumor weights were measured at day
10 after injection. Scatter plot illustrates distribution of tumor weights from the two groups of transformed clones. Rate of tumor formation
is similar in both groups, and the average tumor weight is not statistically different (p 5 0.171; one-sided Student's t test).
determined. Nevertheless, we have established that p53 of the p53 protein, evident in p53-dependent reporter
assays and activation of p21CIP1/WAF1. Moreover, the prom-plays a key role in the cellular response to telomere
dysfunction in vivo in both normal and neoplastic cells, inent biphasic cell cycle arrest is also consistent with a
p53 mediated checkpoint response and the establisheda role that is particularly prominent during the early
stages of genomic crisis. Furthermore, this p53-medi- role of p21CIP1/WAF1 as an inhibitor of both the G1 and G2
phases of the cell cycle. Significantly, loss of p53 res-ated pathway can dramatically affect the consequence
of telomere shortening during carcinogenesis. cues the cell cycle arrest in MEFs and the apoptotic
elimination of male germ cells. Together these data es-
tablish p53 as an important effector in a pathway acti-Telomere Dysfunction Activates
a p53-Dependent Checkpoint vated by loss of telomere function.
The mTR2/2 mouse serves as a model to study the con-
sequences of telomere loss in vivo. Similar to well-char- Crisis: Friend or Foe?
Human cells require inactivation of Rb and/or p53 toacterized DNA damage checkpoints, the specific re-
sponse to telomere dysfunction can be either growth bypass the major checkpoint that limits replicative life-
span: cellular senescence. Rb/p53 inactivation allowsarrest or apoptosis depending upon cell type, p53 path-
way status, and physiological context. In male germ continued cell division beyond senescence, progressive
telomere shortening, and entry into crisis, from whichcells and lymphocytes, telomere loss elicits a strong
apoptotic response, whereas MEFs experience a potent only rare survivors will emerge. Our in vivo and cell
culture data suggest that the period defined as crisis inbiphasic cell cycle block. In the case of MEFs, this arrest
occurs in concert with the stabilization and activation cultured cells can be divided into two phases: ªearly
p53 Mediates the Adverse Effects of Telomere Loss
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Figure 5. A Model for Crisis and Tumorigenesis
Cell division in the absence of telomerase results in telomere shortening. Oncogene activation or tumor suppressor deletion can facilitate
growth beyond senescence, leading to further telomere shortening. In early crisis, p53 is activated, leading to cell death or permanent growth
arrest. Inactivation of the p53 DNA damage pathway (dotted black arrow) allows rare cells to continue to divide and bypass the p53 checkpoint.
Alternatively, cells that deactivate p53 DNA damage responses early proceed unimpeded through early crisis (blue arrow). Both pathways
lead to genetic catastropheÐmassive genetic instability in the setting of telomere dysfunction and p53 loss. This results in cell death by p53-
independent mechanisms unless cells reestablish telomere maintenance either via telomerase or ALT or develop adaptive responses (red
arrow) to tolerate genomic instability.
crisisº and ªlate crisis,º the latter we term ªgenetic catas- and p53 have been impaired, the fate of the cell is un-
predictable and depends on other stochastic genetictropheº (Figure 5). Cell death in early crisis is p53 depen-
dent. Loss of p53 can circumvent this checkpoint, lead- changes. Cells that cannot reestablish telomere mainte-
nance or tolerate genomic instability (e.g., germ cellsing eventually to p53-independent apoptosis, perhaps
as a consequence of uncontrolled chromosome fusion- in G7 and G8) will die. In other cells, increased aneu-
ploidy or fusion-bridge-breakage may facilitate geneticbridge-breakage cycles and progressive genomic insta-
bility. Early crisis accounts for efficient germ cell deple- changes that promote survival, such as oncogene acti-
vation, tumor suppressor deletion, reactivation of telo-tion in G6 mTR2/2 p531/1, whereas the altered histology
of G7 and G8 mTR2/2 p532/2 testis provides experimen- mere maintenance mechanisms, or adaptation to telo-
mere dysfunction (e.g., Myc/RAS-expressing G6 mTR2/2tal support for late crisis. Thus, the rampant genetic
instability of the G7 and G8 mTR2/2 p532/2 cells is asso- p532/2 MEFs) (Figure 5).
Although loss of telomere and p53 function facilitatesciated with loss of cell viability despite p53 deficiency,
implying that advanced genomic catastrophe gives way initiation of transformation, the reconstitution of telo-
merase activity greatly improved the capacity of trans-to a p53-independent process.
To understand the interrelationship of crisis, telomeres, formed foci to yield immortal cultures. Thus, the acti-
vation of telomerase enhances cell survival possiblyand tumorigenic potential, we exploited the multistage
features of the MEF cooperation assay. Focus formation through avoidance of the p53-independent death of ge-
netic catastrophe (Figure 5). The fact that many humanis thought to reflect the earliest stages of oncogenic
transformation. The ability of exogenous telomerase to tumors that are telomerase positive still have short telo-
meres supports the idea that telomerase activation oc-reduce focus formation in p53 null cells with short dys-
functional telomeres suggests that genetic instability curs late in tumorigenesis. Together with previous work,
our data indicated that, first, during the early stagesassociated with telomere loss can serve as an engine
driving initiation of transformation, but only in the ab- of tumorigenesis, cells suffer telomere shortening, and
second, that telomerase activation is advantageous pri-sence of functional p53 (Figure 5). This unanticipated
result indicates that telomere dysfunction cooperates marily in later stages of tumorigenesis. The observation
that mTR expression facilitates subcloning efficiencywith p53 deficiency to facilitate cellular transformation.
This finding runs counter to the prevailing view that of Myc/RAS-transformed late-generation mTR2/2 cells
supports the importance of telomere maintenancelate crisis represents a second telomere-based block
to tumorigenesis in cells that have subverted the senes- mechanisms during later stages of carcinogenesis.
cence checkpoint (Counter et al., 1992). We propose
that late crisis is not a checkpoint but instead represents Telomere Dysfunction, INK4a, and p53
These findings stand in sharp contrast to those obtainedthe consequence of unimpeded proliferation in the ab-
sence of two powerful genome-stabilizing factors: func- from our analysis of mice null for both mTR and INK4a.
In the mTR/INK4a double null mice, loss of telomere func-tional telomeres and p53. Once both telomere function
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Anti-p53 Immunohistochemistrytion was associated with a marked reduction in tumor
Early-passage (p6) MEF cultures were fixed in acetone:methanolincidence in vivo and a decreased rate of Myc/RAS focus
and blocked in 6% BSA in PBS. Monoclonal anti-p53 antibody (Ab1,formation in MEFs (Greenberg et al., 1999). Most signifi-
Oncogene Science) was diluted 1:500 and incubated on cells over-
cantly, in contrast to late-generation mTR2/2 p532/2 night at 48C followed by biotinylated secondary antibody (Vector
MEFs, addition of mTR to the Myc/RAS cotransfections Laboratories) and streptavidin peroxidase (Vector Laboratories). Di-
aminobenzidine was used as the final chromogen, and hematoxylinof late-generation mTR2/2 INK4a2/2 MEFs enhanced the
was used as the nuclear counterstain.rate of focus formation relative to empty vector controls.
The mTR2/2 INK4a2/2 study provides strong in vivo sup-
port for the hypothesis that maintenance of telomere MEF Cell Cycle Profiles and BrdU Incorporation Assays
Early-passage MEF cultures were pulsed with BrdU at a final con-function is required for efficient tumorigenesis. INK4a2/2
centration of 10 mM for 3.5 hr. Cells were processed as previouslymice lack functional p19ARF, a modulator of p53 function
described (Serrano et al., 1997).activated by inappropiate oncogene activation, but re-
tain intact DNA damage±induced p53 activation (Kamijo
MEF Transformation Assayet al., 1997). In mTR2/2 INK4a2/2 mice, it is likely that
Expression constructs for c-myc, and mutant H-RAS have beentelomere dysfunction activates p53 via a DNA damage
described previously (Mukherjee et al., 1992). Early-passage MEFssignaling pathway and results in growth arrest or apo-
were cotransfected as described previously (Mukherjee et al., 1992)
ptosis, limiting the efficiency of carcinogenesis with 2 mg each of the relevant expression constructs plus 20 mg of
The findings of this study may have implications for genomic DNA as carrier. At 9 to 12 days posttransfection, foci were
the use of telomerase inhibitors as an anti-tumor therapy scored visually and confirmed by microscopic examination to be
transformed morphologically. For subcloning efficiency, foci werein human cancers. The cooperative interactions of dys-
picked into 48-well plates, then expanded into 10 cm plates. A focusfunctional telomeres and p53 deficiency in cancer initia-
that was capable of growing to confluency in a 10 cm plate wastion, together with the capacity for cells to activate ALT,
judged to be established. For tumor formation assays, 2 3 106 cells
raise questions as to whether telomerase inhibitors were injected subcutaneously into SCID mice. At day 10, animals
would have a beneficial effect in p532/2 tumors. How- were sacrificed, and tumors were weighed.
ever, in cancer cells harboring intact DNA damage re-
sponse pathways such as those with an INK4a2/2 p531/1
Telomere Length Analyses
genotype, pharmacological inhibition of telomerase and Telomere length determination was performed on early-passage
subsequent telomere shortening would be predicted to MEF cultures as well as primary thymocytes as described previously
(Rufer et al., 1998; Rudolph et al., 1999). Telomere-specific FITC-be more therapeutically efficacious.
conjugated (C3TA2)3 PNA probe was obtained from PerSeptive Bio-
systems. Day to day variations in the linearity of the flow cytometer
Experimental Procedures
were controlled by the use of FITC-labeled fluorescence beads (Flow
Cytometry Standards Corporation). For telomere length determina-
Mating Scheme
tion of MEFs, littermate MEF cultures were assayed simultaneously
mTR1/2 mice were mated with p531/2 (Jackson) mice to generate
to reduce experimental variability. At least two independent determi-
double heterozygotes (mTR1/2 p531/2). These mice were inter-
nations of the same cultures were performed. For primary thymo-
crossed to generate G1 mTR2/2 p531/1, p531/2, and p532/2 animals.
cytes, age-matched animals were sacrificed, and single-cell sus-
All mice are in a mixed genetic background (WW6/C57BL/6), and
pensions were prepared by mechanical disruption and filtering of
cousin mating schemes were employed to prevent generation of
thymus tissue. Three independent age-matched sets of animals
substrains (Lee et al., 1998). G1 mTR2/2 p531/2 mice were mated
were used.
to generate G2 mice and so on.
Metaphase SpreadsImmunoblotting
Early-passage MEF cultures were incubated in 0.1 mg/ml colec-Testis was dounced in 1% SDS, 20 mM Tris and protease inhibitors
imid for 1.5 hr then processed as described previously (Rudolph etand boiled for 5 min. Staph protein A-Sepharose covalently coupled
al., 1999).to anti-p53 monoclonal antibody 421 (Oncogene Science) was incu-
bated with 1 mg of extract, washed three times, denatured and
subjected to SDS-PAGE, transferred, and probed with a sheep poly- Acknowledgments
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